Phase II, Open Label, Clinical Study to Assess the Safety and Activity of SRT501 Alone or in Combination with Bortezomib in Patients with Multiple Myeloma

Project: Research

Participants

Colleges, School and Institutes

Short titlePhase II, Open Label, Clinical Study to Assess the Safety and Activity of SRT501 Alone or in Combination with Bortezomib in Patients with Multiple Myeloma
StatusFinished
Effective start/end date30/04/0931/12/12